An interdisciplinary biopharmaceutical company driven by cutting-edge technologies such as artificial intelligence, quantum mechanics, and molecular simulation algorithms .
Accelerate drug discovery with integrated in silico DMTA solutions
DIVAMICS is an interdisciplinary biopharmaceutical company driven by cutting-edge technologies such as artificial intelligence, quantum mechanics, and molecular simulation algorithms.
Integrating AI tools into molecular simulation, the multiscale Molecular Dynamics simulation platform has become Divamics’ most striking feature. By elucidating the flexibility of the target and simulating the target-ligand interactions under physiological environment, we are able to accelerate your drug discovery project with more detailed dynamic structural information and molecular mechanism.
Continuous optimization of the algorithms and data structure on Divamics’ platform allows us to direct optimal computational resources to each project, screening and optimizing the right drug molecules in an accurate and efficient way that could reduce the cost of compound synthesis prior to PCC by about 70%.
An experienced diverse team to remove obstacles in your drug discovery projects
Divamics’ dedicated team features a wide range of backgrounds with 20+ years of experiences in medicinal chemistry, computational biology and algorithm development. The synergistic nature of our team delivers faster and more cost-effective solutions to you.
Whatever your project type is, whether it be small molecule, PROTAC or peptide therapeutics, etc., our extensive experience can always add insights and value.
A skilled manager + scientist + engineer team with related experience will be designated to each project to allocate best-fit resources and deliver first-time-right solutions.
Working alongside with your own R&D team, we share our experience and incubate new ideas, to provide innovative guidance and offer collaborative support.
Testimonials from cresset discovery cusrtomers